Foghorn Therapeutics Inc.
FHTXNASDAQHealthcare● Active
$3.71
$-0.02(-0.54%)
Market Cap$217828569
P/E Ratio—
52W High$6.95
52W Low$3.27
Foghorn Therapeutics Inc.（FHTX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FHTX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $30.91M | $22.60M | $34.16M | $19.23M | $1.32M |
| Cost of Revenue | $3.33M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $27.58M | $22.60M | $34.16M | $19.23M | $1.32M |
| Gross Margin %(computed) | 89.22% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $85.47M | $94.53M | $109.69M | $105.62M | $80.33M |
| G&A Expenses | $27.55M | $28.36M | $32.37M | $30.75M | $21.73M |
| Total Operating Expenses | $109.68M | $125.28M | $142.06M | $136.37M | $102.05M |
| Operating Income | ($82.11M) | ($102.68M) | ($107.91M) | ($117.14M) | ($100.73M) |
| Operating Margin %(computed) | -265.64% | -454.31% | -315.93% | -609.20% | — |
| Interest Income | $8.74M | $11.90M | $10.88M | $5.67M | $0.06M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $1.91M |
| Income Before Tax | ($74.28M) | ($86.62M) | ($94.20M) | ($108.88M) | ($101.32M) |
| Income Tax Expense | $0.00M | $0.00M | $4.23M | $0.00M | $0.00M |
| Net Income | ($74.28M) | ($86.62M) | ($98.43M) | ($108.88M) | ($101.32M) |
| Net Margin %(computed) | -240.33% | -383.24% | -288.17% | -566.27% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.18 | $-1.58 | $-2.34 | $-2.62 | $-2.78 |
| Wtd Avg Shares | 62.98M | 54.90M | 41.97M | 41.59M | 37.17M |
| EBITDA | ($78.78M) | ($97.17M) | ($104.45M) | ($113.82M) | ($96.19M) |
| EBITDA Margin %(computed) | -254.86% | -429.90% | -305.83% | -591.93% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Foghorn Therapeutics Inc.
关于Foghorn Therapeutics Inc.（FHTX）损益表
Foghorn Therapeutics Inc.（FHTX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，FHTX实现营收$0.03B，毛利润$0.03B（毛利率89.22%），净利润($0.07B)（净利率-240.33%）。
常见问题
FHTX · 4 问Foghorn Therapeutics Inc.（FHTX）2025财年营收为$0.03B，同比up36.8%。
FHTX revenueFHTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08